Free Due Diligence

 MRES   Quick summary to get up to speed…

Update>

I noticed on Twitter, M2Bios products are starting to appear in stores. Here is the partial list and remember, this is just one of their divisions. The packaging is exceptional in fact, everything the company has done has been top notch quality with backed up science. The purple tea recently discussed can single handedly provide huge revenues for the company since the antioxident levels appear to be very high and greater than Green Tea. The CEO is headed to Kenya this week. You can reference the recent press release with more details following this product post.

Upcoming Products

M2Bio Sciences is thrilled to announce a new range of CBD infused premium products for 2023, each of which contains pharmaceutical-grade organic CBD. These sumptuous products are designed to make CBD part of one’s daily routine by pairing it with flavourful, nutritious locally-sourced organic produce. The range will consist of the following products:

Medspresso CBD infused Sao Tome Roasted Cacao Dark Chocolate

Medspresso CBD infused All Natural Apple Crumble Tea (Apple, Cinnamon, Rooibos)
Medspresso CBD infused All Natural Vanilla Sunrise Tea (Vanilla, Rooibos, Liquorice)
Medspresso CBD infused All Natural Energy Booster Tea (Guarana, Orange, Rooibos)
Medspresso CBD infused All Natural After Eight Tea (Chocolate, Mint, Rooibos)

Liviana CBD infused Limpopo Raw Peanut Butter
Liviana CBD infused Limpopo Medium Roast Peanut Butter
Liviana CBD infused Limpopo Medium Roast Extra Crunchy Peanut Butter
Liviana CBD infused Limpopo Dark Roast Peanut Butter
Liviana CBD infused Mpumalanga Macadamia and Karoo Pistachio Butter

Liviana CBD infused Heritage Raspberry Vinegar
Liviana CBD infused 18 year aged Oak Barrel Balsamic Vinegar

Liviana CBD infused Estate Select Hummus
Liviana CBD infused Eureka Lemon Hummus
Liviana CBD infused Chilli Pepper Trilogy Hummus

Liviana CBD infused Piquante Red Pepper Pesto
Liviana CBD infused Admiral Yellow Pepper Pesto
Liviana CBD infused Supergreen Pesto
Liviana CBD infused Portebello Mushroom Pesto

Liviana CBD infused Dried Papaya (preservative free, no added sugar, no sulphites)
Liviana CBD infused Dried Grapefruit preservative free, no added sugar, no sulphites)
Liviana CBD infused Dried Orange (preservative free, no added sugar, no sulphites)
Liviana CBD infused Dried Pineapple (preservative free, no added sugar, no sulphites)
Liviana CBD infused Dried Banana (preservative free, no added sugar, no sulphites)
Liviana CBD infused Dried Mango (preservative free, no added sugar, no sulphites)

“Looking forward, 2023 will be a fantastic year for the Food and Beverage Divsion of M2Bio Sciences. We are really excited to bring these scrumptious products to market and share our passion for food and health with the South African consumer” – Michael Sachar, CEO of Food and Beverage at M2Bio Sciences.

M2Bio Sciences Food and Beverage CEO Provides Update (einpresswire.com)

 You may want to follow the CEO here… M2Bio Sciences (@m2bio) / Twitter
Jeff Robinson just started doing daily 1 minute updates just to check in with investors. I think this is a great idea by him and haven’t seen any other company do this.
I have mentioned Jeff’s previous successes along with the team he had including some very reputable, well known investors in the world. Take note of the spin out and dividend they paid to shareholders. I believe he will use this same model with m2bio
____________________________________________________________________________________________________________________________________-________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Recent Press…

MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits

MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits | MRES – Institute of Biomedical Research Corp. | News | OTC Markets

Backed by science…Polyphenols, organic compounds found abundantly in plants, have become an emerging field of interest in nutrition in recent decades.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160559/

Animal, human and epidemiologic studies show that various polyphenols have antioxidant and anti-inflammatory properties that could have preventive and/or therapeutic effects for cardiovascular disease, neurodegenerative disorders, cancer, and obesity

Incredible ,new, untapped sector. A must watch video  explaining this new investment arena in which M2Bio is moving into ahead of the crowd..

MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access

MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access | MRES – Institute of Biomedical Research Corp. | News | OTC Markets

MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing

MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing | MRES – Institute of Biomedical Research Corp. | News | OTC Markets

MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX

MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX | MRES – Institute of Biomedical Research Corp. | News | OTC Markets

Ze-ev Krein, an interdisciplinary scientist and the founder of JDAX, will guide M2Bio’s drug discovery program and will spearhead the development of smart contracts that enable global communities to actively participate in and potentially hold ownership stakes in the transformative discoveries arising from M2Bio’s research efforts. JDAX: Main page

MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines

MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines | MRES – Institute of Biomedical Research Corp. | News | OTC Markets

M2Bio Sciences is delighted to announce it has signed an agreement with the University of Pretoria/Universiteit van Pretoria and Enterprises University of Pretoria to continue research into Plant Medicines, and the application of Artificial Intelligence and Machine Learning to drug discovery and forensic science.

MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions

MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions (prnewswire.com)

*CEO with skin in the game and a long record of success in various venues. It’s important to  do your own homework  . Unfortunately, many will miss this since its labeled a scam by those who aren’t capable of doing any homework. I am providing this due diligence so you can see some of Jeff Robinson’s accurate background accomplishments along with the many businessmen he’s involved with.

Time to review what he did with PRTG (Portage) while it was a pink sheet stock, spinning out BHVN and later bought out by Pfizer…

Bontan Corporation Inc.
Notes to Consolidated Financial Statements
(Canadian Dollars)
September 30, 2005 and 2004
(Unaudited –see Notice to Reader dated November 14, 2005)8.
COMMITMENTS AND CONTINGENT LIABILITIES – Continued

(g)
On August 1, 2005, The Company entered into a consulting contract with Mr. Jeffrey Robinson, brother of Mr. Terence Robinson, the former chief executive officer and currently a consultant with the Company. The contract is for one year expiring on July 30, 2006 and is for a sum of $ 86,400 payable in 120,000 common shares under the 2003 Consultants Compensation Plan. 10,000 shares were issued on the date of signing and the balance to be issued at the rate of 2,500 per week. Under the contract, Mr. Robinson will provide public relation services and is responsible for the web site contents and data base maintenance. The Contract is not subject to automatic renewal.

(e)
On August 15, 2005, the company renewed consulting contract with Mr. John Robinson, brother of Mr. Terence Robinson, the former chief executive officer and currently a consultant with the Company and sole owner and president of Current Capital Corp., a firm with which the Company has media relation contract. (see 8.a). The contract was retroactive to July 1, 2005 for one year term, not subject to automatic renewal. The consulting fee was agreed to be 120,000 common shares under 2003 Consultants Compensation Plan. 107,048 shares were issued on the renewal date and balance to be issued upon registration of a new Compensation Plan. Mr. Robinson will provide services that include monitoring the oil and gas projects that the Company may participate from time to time.

https://ir.portagebiotech.com/node/6806/html

https://www.linkedin.com/in/alwaysfun/?originalSubdomain=es

Co-FounderCo-Founder
Portage Biotech IncPortage Biotech Inc
Jun 2013 – Present · 9 yrs Jun 2013 – Present · 9 yrs
Connecticut, United StatesConnecticut, United States
Co-founded Portage Biotech in July/2013.Portage(PRTG/NASDAQ) became public as the result of a merger between Bontan Corporation a public entity and Portage, a London/England-based private entity. The controlling shareholders of Portage are Dr.Greg Bailey ( co-founder of Medivation Inc-since taken over by Pfizer for $14 B ) and Jim Mellon, a London-based investor and financier.

Portage invested an initial $3 M into a Yale University-based biotech company called Biohaven. Biohaven Pharmaceutical (BHVN) IPO’d in May/2017 on the NYSE and has a current market cap of $8 Billion( $122/share). Portage paid a stock dividend in Biohaven shares (01/18) to its shareholders totaling 6 million shares ( today’s value >$730 M ). Portage is now focused on new drug development for cancer treatments and is listed on NASDAQ under the symbol PRTG

PRTG $10.13 with Nasdaq up-list from pennies. PRTG spun out BHVN to shareholders and was recently bought out by Pfizer for over $144.00 a share…

More tidbits…

Pfizer Buys Biohaven In A $12 Billion Deal That ‘Couldn’t Have Come At A Better Time’

https://finance.yahoo.com/m/a73df6be-b246-3daa-b611-e7e1855c3352/pfizer-buys-biohaven-in-a-12.html

PRTG  was originally founded by the CEO of  MRES and his brother. It was a a pink sheet penny stock and both PRTG and BHVN were added to the big board and as posted, later bought out by Pfizer for $144.00 a share.

Here is one of Jeff’s brothers Terrence and the history with PRTG. You will recognize some other names in there like Dr Bailey who had numerous interviews with   CEO Jeff Robinson. Search Jim Mellon and see who he is.

(4) Terence Robinson | LinkedIn

Look at the dividend PRTG paid to shareholders below.

Co-Founder
Co-Founder
Portage Biotech Inc
Portage Biotech Inc
Jun 2013 – Present · 9 yrs
Jun 2013 – Present · 9 yrs
Connecticut, United States
Connecticut, United States

Co-founded Portage Biotech in July/2013.Portage(PRTG/NASDAQ) became public as the result of a merger between Bontan Corporation a public entity and Portage, a London/England-based private entity. The controlling shareholders of Portage are Dr.Greg Bailey ( co-founder of Medivation Inc-since taken over by Pfizer for $14 B ) and Jim Mellon, a London-based investor and financier. Portage invested an initial $3 M into a Yale University-based biotech company called Biohaven. Biohaven Pharmaceutical (BHVN) IPO’d in May/2017 on the NYSE and has a current market cap of $8 Billion( $122/share). Portage paid a stock dividend in Biohaven shares (01/18) to its shareholders totaling 6 million shares ( today’s value >$730 M ). Portage is now focused on new drug development for cancer treatments and is listed on NASDAQ under the symbol PRTG

Jim Mellon…

Jim Mellon – Wikipedia

https://en.wikipedia.org/wiki/Jim_Mellon

He also holds non-executive directorships at Condor Gold PLC, Bradda Head Limited (formerly Life Science Developments) and Portage Biotech Inc.

Juvenescence, a biotech company, was founded by Mellon and four others, Greg Bailey,

This M2Bio entity was moved from WUHN to MRES

*Numerous streams of revenue potential.

*Exceptional product line includes CBD infused coffees, teas, medicinal mushrooms, olive oils, balms, cosmetics and more.
https://m2bio.co/brands_and_products/

*Psilocybin division … with Tremendous Science and Research in the sector. They have 3 published papers.
https://m2bio.co/science-research/

*Hemp & Mycelium Division…
Sustainable Packaging
https://m2bio.co/wp-content/uploads/2021/08/Hemp-Plastics.pdf

*Cannabis Manufacturing… MediGrow Africa – Tsime Pharmaceuticals
Acquisition to cultivate, extract and process cannabis in Lesotho – licensed for 10 years.
Look at this operation. https://www.medigrowafrica.com/about-us
The Founder – Willem Daniel Jonker and now CFO of M2Bio (MRES)

The founder of Medigrow Africa is a chartered Accountant (South Africa) by training. He was a senior partner at Allan Gray (www.allangray.co.za), the largest independent investment manager in South Africa, until 1993. Thereafter he moved into the field of private equity, arranging funding for companies such as Medigrow Africa. linkedin.com/in/willem-jonker-9271a91

 *Formation of Blockchain Research and Technology Group

https://feeds.issuerdirect.com/news-release.html?newsid=7261780883987446
The company is equally committed to value creation for local communities and has recently received an endorsement from the Lesotho government to develop blockchain projects that support these endeavours.
In its first phases, a seed-to-sale provenance tool for CBD and related products enables M2Bio and the Kingdom of Lesotho to bring trusted bioceutical to the global market. That said, the Research Group has aspirations that are far more wide-reaching.

*Created a new division for Ketamine IV & Personalized Supercharged Vitamin IV Drip
https://feeds.issuerdirect.com/news-release.html?newsid=8840965826654119

M2Bio White paper Publications…


  • Phytochemical, Cytotoxicity, Antioxidant and
    Anti-Inflammatory Effects of Psilocybe Natalensis
    Magic Mushroom

Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom (m2bio.co)

  • Efects and safety of Psilocybe
    cubensis and Panaeolus
    cyanescens magic mushroom
    extracts on endothelin‑1‑induced
    hypertrophy and cell injury
    in cardiomyocytes

Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes (m2bio.co)

  • Anti-Inflammatory Effects of Four
    Psilocybin-Containing Magic Mushroom Water
    Extracts in vitro on 15-Lipoxygenase Activity and
    on Lipopolysaccharide-Induced
    Cyclooxygenase-2 and Inflammatory Cytokines
    in Human U937 Macrophage Cells

There is much more and I suggest you go through all of it..    Press Releases – M2Bio Sciences

JOIN NOW